0001562180-22-002665.txt : 20220316 0001562180-22-002665.hdr.sgml : 20220316 20220316111619 ACCESSION NUMBER: 0001562180-22-002665 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220314 FILED AS OF DATE: 20220316 DATE AS OF CHANGE: 20220316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lai Quintin J CENTRAL INDEX KEY: 0001744326 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 22743793 MAIL ADDRESS: STREET 1: 530 HERMAN 0. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-03-14 false 0000105770 WEST PHARMACEUTICAL SERVICES INC WST 0001744326 Lai Quintin J 530 HERMAN O. WEST DRIVE EXTON PA 19341 false true false false VP Corp Development & Strategy Common Stock 2022-03-14 4 M false 2440.00 94.27 A 7811.8424 D Common Stock 2022-03-14 4 M false 5576.00 83.47 A 13387.8424 D Common Stock 2022-03-14 4 S false 1271.00 367.1156 D 12116.8424 D Common Stock 2022-03-14 4 S false 405.00 367.9442 D 11711.8424 D Common Stock 2022-03-14 4 S false 1254.00 369.8575 D 10457.8424 D Common Stock 2022-03-14 4 S false 446.00 370.9431 D 10011.8424 D Common Stock 2022-03-14 4 S false 600.00 371.887 D 9411.8424 D Common Stock 2022-03-14 4 S false 900.00 372.924 D 8511.8424 D Common Stock 2022-03-14 4 S false 2940.00 374.4492 D 5571.8424 D Common Stock 2022-03-14 4 S false 200.00 374.92 D 5371.8424 D Stock Options (Right to buy) 94.27 2022-03-14 4 M false 2440.00 0.00 D 2018-02-05 2027-02-05 Common Stock 2440.00 34640.00 D Stock Options (Right to buy) 83.47 2022-03-14 4 M false 5576.00 0.00 D 2018-02-21 2027-02-21 Common Stock 5576.00 29064.00 D The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $366.50 to $367.42, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $367.56 to $368.22, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $369.40 to $370.36, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $370.41 to $371.32, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $371.65 to $372.40, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $372.70 to $373.46, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $373.86 to $374.83, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Ryan Metz as Agent for Quintin J. Lai 2022-03-16